Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.22 USD | +2.90% | +8.57% | +60.43% |
05-13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
05-10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.43% | 77.27M | |
+26.90% | 49.18B | |
+0.99% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.80% | 26.09B | |
-22.32% | 18.71B | |
+7.73% | 13.26B | |
+32.50% | 12.32B | |
+0.29% | 11.99B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Baird Adjusts Instil Bio's Price Target to $24 From $31, Keeps Outperform Rating